Similarly, Filipazzi et al. reported an expansion of CD14+CD11b+HLA-DR−/low M-MDSCs in fresh whole blood from 70 advanced melanoma patients suggesting an inverse correlation with immune responses to cancer vaccine (138). Here, CD14 is linked to melanoma.